Literature DB >> 15288744

Clinical predictors of bioterrorism-related inhalational anthrax.

Demetrios N Kyriacou1, Adam C Stein, Paul R Yarnold, D Mark Courtney, Regina R Nelson, Gary A Noskin, Jonathan A Handler, Ralph R Frerichs.   

Abstract

Limitation of a bioterrorist anthrax attack will require rapid and accurate recognition of the earliest victims. To identify clinical characteristics of inhalational anthrax, we compared 47 historical cases (including 11 cases of bioterrorism-related anthrax) with 376 controls with community-acquired pneumonia or influenza-like illness. Nausea, vomiting, pallor or cyanosis, diaphoresis, altered mental status, and raised haematocrit were more frequently recorded in the inhalational anthrax cases than in either the community-acquired pneumonia or influenza-like illness controls. The most accurate predictor of anthrax was mediastinal widening or pleural effusion on a chest radiograph. This finding was 100% sensitive (95% CI 84.6-100.0) for inhalational anthrax, 71.8% specific (64.8-78.1) compared with community-acquired pneumonia, and 95.6% specific (90.0-98.5) compared with influenza-like illness. Our findings represent preliminary efforts toward identifying clinical predictors of inhalational anthrax.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15288744     DOI: 10.1016/S0140-6736(04)16769-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

Review 1.  Anthrax infection.

Authors:  Daniel A Sweeney; Caitlin W Hicks; Xizhong Cui; Yan Li; Peter Q Eichacker
Journal:  Am J Respir Crit Care Med       Date:  2011-08-18       Impact factor: 21.405

2.  Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity.

Authors:  Demetrios N Kyriacou; Debra Dobrez; Jorge P Parada; Justin M Steinberg; Adam Kahn; Charles L Bennett; Brian P Schmitt
Journal:  Biosecur Bioterror       Date:  2012-07-30

3.  Plasma assisted decontamination of bacterial spores.

Authors:  Spencer P Kuo
Journal:  Open Biomed Eng J       Date:  2008-07-25

4.  Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculature.

Authors:  Robert E Bolcome; Sarah E Sullivan; René Zeller; Adam P Barker; R John Collier; Joanne Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

5.  Complement C5 inhibition protects against hemolytic anemia and acute kidney injury in anthrax peptidoglycan-induced sepsis in baboons.

Authors:  Ravi Shankar Keshari; Narcis Ioan Popescu; Robert Silasi; Girija Regmi; Cristina Lupu; Joe H Simmons; Alonso Ricardo; K Mark Coggeshall; Florea Lupu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-14       Impact factor: 11.205

6.  Spatiotemporal Clustering Analysis and Risk Assessments of Human Cutaneous Anthrax in China, 2005-2012.

Authors:  Wen-Yi Zhang; Li-Ya Wang; Xiu-Shan Zhang; Zhi-Hai Han; Wen-Biao Hu; Quan Qian; Ubydul Haque; Ricardo J Soares Magalhaes; Shen-Long Li; Shi-Lu Tong; Cheng-Yi Li; Hai-Long Sun; Yan-Song Sun
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

7.  Lethal factor and anti-protective antigen IgG levels associated with inhalation anthrax, Minnesota, USA.

Authors:  Mark D Sprenkle; Jayne Griffith; William Marinelli; Anne E Boyer; Conrad P Quinn; Nicki T Pesik; Alex Hoffmaster; Joseph Keenan; Billie A Juni; David D Blaney
Journal:  Emerg Infect Dis       Date:  2014-02       Impact factor: 6.883

Review 8.  Biowarfare and bioterrorism.

Authors:  Michael D Christian
Journal:  Crit Care Clin       Date:  2013-07       Impact factor: 3.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.